A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

NCT00044057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: YM872 (zonampanel), t-PA (alteplase)

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]